What Is P-21?
P-21 is a synthetic 23-amino-acid peptide derived from the CNTF (Ciliary Neurotrophic Factor) receptor α subunit. It was designed at the Buck Institute for Research on Aging to produce BDNF-like activity without requiring the large CNTF protein itself — creating a small, brain-penetrant peptide that stimulates neurogenesis and cognitive function through BDNF-pathway mechanisms.
Mechanism: BDNF Without BDNF
BDNF is one of the most important neurotrophins in the brain — promoting neuron survival, synapse formation, long-term potentiation, and hippocampal neurogenesis. P-21 activates CNTF receptor complexes that share downstream signaling pathways with TrkB (the BDNF receptor) — specifically JAK/STAT and PI3K/Akt — producing BDNF-like neurogenic and neuroprotective effects while bypassing BDNF's delivery limitations.
Neurogenesis Research
Animal studies demonstrated that systemic P-21 administration produced a 23-fold increase in hippocampal neurogenesis — far exceeding what exercise or other known interventions produce. This remarkable neurogenic effect was accompanied by improvements in memory and learning task performance, and preliminary data supports applications in depression, stress-induced cognitive impairment, and age-related cognitive decline.
Quick Reference
Member reference tables summarize the compound's research parameters.
Research Indications
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Peptide Interactions
This member section summarizes reported compound interactions and evidence limitations.
Reported Research Time Points
This member section summarizes reported research time points.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
Quality Indicators
Research Citations
- Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice
Li B, Wanka L, Blanchard J, Liu F, Chohan MO, Iqbal K, Grundke-Iqbal I, 2010, FEBS Letters - Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease
Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Bhakta Iqbal I, Bhakta S, Bhakta S, Grundke-Iqbal I, Iqbal K, 2014, Neurobiology of Disease - Enhancement of neurogenesis and memory by a neurotrophic peptide in mild to moderate traumatic brain injury
Chohan MO, Bragina O, Bhakta Iqbal SJ, Bhakta S, Bhakta S, Bhakta S, Bhakta S, Bhakta S, Iqbal K, Bhakta Iqbal SJ, 2015, Neuroscience - Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
Baazaoui N, Iqbal K, 2017, Neurobiology of Aging - Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound
Baazaoui N, Iqbal K, 2022, Biomolecules - Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder
Fuchs C, Gennaccaro L, Bhakta S, Bhakta S, Bhakta S, Bhakta S, Bhakta S, Bhakta S, 2024, Journal of Neurodevelopmental Disorders - Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivity
Curin M, Garmatiuk T, Resch-Marat Y, 2018, Allergy - Structure of the complex of Cdc42Hs with a peptide derived from P-21 activated kinase
Gizachew D, Guo W, Chohan KK, 2000, Biochemistry - Concerted motion of a protein-peptide complex: backbone dynamics studies of an (15)N-labeled peptide derived from P(21)-activated kinase bound to Cdc42Hs.GMPPCP
Gizachew D, Oswald RE, 2001, Biochemistry - Effectiveness and safety of bivalirudin anticoagulation therapy in adult patients receiving extracorporeal membrane oxygenation: A systematic review and meta-analysis
Hu Y, Yu L, Yang W, 2025, Medicine (Baltimore) - Clinical ApoA-IV amyloid is associated with fibrillogenic signal sequence
Canetti D, Nocerino P, Rendell NB, 2021, J Pathol